Інформація призначена тільки для фахівців сфери охорони здоров'я, осіб,
які мають вищу або середню спеціальну медичну освіту.

Підтвердіть, що Ви є фахівцем у сфері охорони здоров'я.

"Kidneys" Том 8, №4, 2019

Back to issue

The Renal Association Clinical Practice Guideline Acute Kidney Injury (AKI), August 2019

Authors: Suren Kanagasundaram (chair)(1), Caroline Ashley(2), Sheetal Bhojani(3), Alma Caldwell(4), Timothy Ellam(5), Amrit Kaur(6), David Milford(7), Chris Mulgrew(8), Marlies Ostermann(9)
(1) — Consultant Nephrologist, Newcastle upon Tyne Hospitals NHS Foundation Trust Honorary Clinical Senior Lecturer, Institute of Cellular Medicine, Newcastle University
(2) — Renal Pharmacist, Royal Free Hospital
(3) — Consultant Paediatrician with Special Interest in Nephrology, University Hospital Wishaw, NHS Lanarkshire
(4) — Patient representative
(5) — Consultant Nephrologist, Newcastle upon Tyne Hospitals NHS Foundation Trust
(6) — Consultant Paediatric Nephrologist, Royal Manchester Children’s Hospital
(7) — Consultant Paediatric Nephrologist, Birmingham Children’s Hospital
(8) — Consultant Nephrologist, Royal Devon and Exeter NHS Foundation Trust
(9) — Consultant in Critical Care and Nephrology, Guy’s and St. Thomas’ NHS Foundation Trust

Categories: Nephrology

Sections: Medical forums

print version


Summary of clinical practice guidelines

1. Definition, Epidemiology and Outcomes

Guideline 1.1 — Adults and Paediatrics

We recommend that the Kidney Disease: Improving Global Outcomes (KDIGO) system for the diagnosis and staging of AKI should be adopted; serum creatinine-based criteria should be applied according to the current NHS England biochemical detection algorithm. (1B)

We suggest that, when the true, reference serum creatinine (SCr) is uncertain, the presence of an active episode of AKI occurring in secondary care can be inferred from frequent SCr testing (e.g. at 12 and 24 hours ...

For the full article you need to subscribe to the magazine.

Back to issue